Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1651
http://purl.obolibrary.org/obo/NCIT_C1651
|
|---|---|
| Preferred Name | Motexafin Lutetium |
| Definitions |
A pentadentate aromatic metallotexaphyrin with photosensitizing properties. Motexafin lutetium preferentially accumulates in tumor cells due to their increased rates of metabolism and absorbs light, forming an extended high energy conformational state that produces high quantum yields of singlet oxygen, resulting in local cytotoxic effects. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A pentadentate aromatic metallotexaphyrin with photosensitizing properties. Motexafin lutetium preferentially accumulates in tumor cells due to their increased rates of metabolism and absorbs light, forming an extended high energy conformational state that produces high quantum yields of singlet oxygen, resulting in local cytotoxic effects. (NCI04) |
|---|---|
| prefLabel | Motexafin Lutetium
|
| label | Motexafin Lutetium
|
| PDQ_Closed_Trial_Search_ID | 42402
|
| code | C1651
|
| prefixIRI | NCIT:C1651
|
| in_subset |
See more
See less
|
| Display_Name | Motexafin Lutetium
|
| Preferred_Name | Motexafin Lutetium
|
| FDA_UNII_Code | 0A85BJ22L6
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C48H66N5O10.2C2H3O2.Lu.H2O
|
| Maps_To | Motexafin Lutetium
|
| CAS_Registry |
156436-90-7
246252-04-0
|
| NSC Number | 695239
|
| NCI_Drug_Dictionary_ID | 42402
|
| Legacy Concept Name | Motexafin_Lutetium
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of cancer using photodynamic therapy. It belongs to the family of drugs called metallotexaphyrins.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42402
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0338310
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |